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PERSPECTIVES IN CLINICAL NEPHROLOGY
D-lactic acidosis: Turning sugar into acids in the
gastrointestinal tract
While an appreciable quantity of organic acids is produced each
day by bacterial metabolism in the gastrointestinal (GI) tract [1,
2], there is usually no acid-base consequence from this acid load
because the rate of production of these acids does not exceed the
capacity of the normal host to metabolize them. Nevertheless,
after jejuninoileal bypass surgery or substantial small bowel
resection, appreciable quantities of acids such as D-lactic acid may
accumulate [3—12]. Hence the stage is set for the development of
D-lactic acidosis when there is a combination of altered GI
anatomy and a change in bacterial flora (such as the use of
antibiotics). A less well recognized clinical association is the
aggravation of the clinical picture when more glucose is supplied
to these bacteria [13—16].
The extent to which production of organic acids will cause
metabolic acidosis also depends on biochemical considerations.
Not only must one consider whether the patient has the enzymatic
machinery to metabolize each added acid, but one must also
appreciate the limitations set by the overall rate of ATP turnover
in cells [17] and the competition between fuels to be the substrate
oxidized to regenerate the ATP needed to perform biologic work
in individual cells [18]. Moreover, there is a quantitative relation-
ship between H removal and ATP regeneration that differs
between individual organic acids [19].
This manuscript is divided into two sections: first we shall
discuss the normal metabolism and functions of organic acids
produced in the GI tract; second, we shall consider the different
types of presentation of organic acidosis where GI bacteria might
have played a central role, highlighting biochemical aspects so
that a more rational design for therapy can be suggested.
Organic acids and the GI tract: Normal physiology
There are two sources of organic acids in the GI tract, diet and
endogenous production. Organic acids of dietary origin do not
usually pose an acid-base threat because the quantity ingested is
not large enough to exceed the capacity of the host to remove
them by metabolic means. In addition, the intake of acids occurs
together with their potassium (K) salts. For example, the citric
acid load ingested each day is small and readily metabolized to
neutral end-products so it only yields a net H load transiently.
Metabolism of the K salt of citrate yields bicarbonate [20].
Overall, after metabolism of the organic acid and its K salt,
bicarbonate ions are produced which minimize a threat from
another H load. Accordingly, we shall focus on endogenous
production of organic acids which are synthesized from neutral
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precursors (largely carbohydrates) in the lumen of the GI tract.
Before discussing factors that influence their rate of production,
we shall review their physiologic functions.
Production of organic acids in the GI tract
Acetic acid (60%), butyric acid (20%), and propionic acid
(20%) are produced normally in the GI tract [1]. The majority of
these organic acids are produced in the caecum because this is the
major site where bacteria flourish together with a source of fuel to
ferment. The fuels fermented by colonic bacteria are non-digest-
ible fiber, some dietary mono- or disaccharides, and starches that
escaped complete digestion and/or absorption upstream in the
small intestine. Organic acids are also produced in more distal
colon sites; here the fuel is almost exclusively undigested starches
and dietary fiber.
The stoichiometry of colonic anaerobic metabolism is that two
molecules of organic acid are produced per molecule of hexose
(Fig. 1). In quantitative terms, close to 25 g (150 mmoles) of
hexose reach the colon, so the overall organic acid production is
in the range of 300 mmoles per day [1, 2]. Anaerobic glycolysis can
occur at a very rapid rate; D- and/or L-lactic acid are the products
of this rapid bacterial metabolism, depending on the predominant
bacterial population. If there is sufficient time, certain bacteria
have the capacity to metabolize D- or L-lactic acid further and the
final product largely becomes acetic acid (Fig. 1). Since the supply
of carbohydrate to the colon is not very large, and that there is
slow transit, acetic acid is the major organic acid produced during
normal anaerobic fermentation [1].
Function of organic acids in the GI tract
The major function of organic acids in the GI tract is to provide
a fuel for oxidative metabolism for mucosal cells of the colon, In
fact, locally produced butyric acid is a major fuel consumed by
colonic mucosal cells [21, 22]. Should the metabolic work of these
mucosal cells (ions pumping for the most part) remain high at a
time when their supply of butyric acid is curtailed (such as
antibiotic therapy), colonic mucosal damage can result [21, 23],
which is a nutritional form of colitis.
One can make a rough deduction concerning the load of butyric
acid that could be metabolized by mucosal cells of the colon based
on their rate of oxygen consumption. Since the splanchnic area
consumes close to 25% oxygen utilized at rest (3 out of 12 mmollmin)
and considering that the liver requires about 75% of this oxygen, the
entire GI tract probably consumes close to 1 mole of 02 per day
[reviewed in 24]. Moreover, the small intestine is the site where most
of the biologically active absorption occurs so the colon may consume
about 250 mmoles of 02 daily. Since the stoichiometry is 5 mmoles
of 02 per mmole butyric acid oxidized, the upper limit on its
oxidation would be 50 mmoles per day. In addition, since butyric acid
supplies only half of the needed ATP in colonic mucosal cells [21,
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(Fig. 2). The acetic acid has two major fates. In the fed state, it is
a good substrate for hepatic lipogenesis [34]. In contrast, oxida-
tion is the principal pathway between meals, with most of the
acetic acid oxidation taking place in organs other than the liver
[24]. With an oxygen consumption rate of 12 mmol/min, the
maximum rate of oxidation of acetic acid would be 6 mmol/min
because the stoichiometry is 2 mmoles of 02 per mmole acetic
acid oxidized. Obviously this is a gross overestimate because other
fuels, such as glucose in the brain [35] and lactate in the kidney
[36], are the usual fuels oxidized in normal subjects. The meta-
bolic and biochemical aspects of these processes are addressed
later in this paper.
Metabolic acidosis due to over-production of organic acids in
the GI tract
2 Acetate- + 2 002
Fig. 1. Anaerobic fermentation by bacteria in the GI tract. The product of
fermentation reactions depend on the supply of glucose (hexoses), the
bacterial population, the local pH, and the time that is available for these
reactions to occur. For more discussion, see text. The 2 H accompany
pyruvate, lactate and acetate anions.
221, it follows that when more than 25 mmoles of butyric acid are
produced, the excess must be metabolized by other organs, excreted
as their NH4 salts, or eliminated in the feces as the free acid if
acid-base balance is to be maintained.
Absorption of organic acids from the GI tract
There is much less known about the process of absorption of
organic acids as compared to the major nutrients in the GI tract.
The following general statements reflect the bulk of the data
[25—321. The site of absorption depends on where the organic
acids are produced. Although the small intestine has a large
capacity to absorb organic acids, few are absorbed here as there is
normally little production in the bacteria-poor lumen of the small
intestine. Since most organic acids are produced in the colon,
most are absorbed there. There are two major proposed mecha-
nisms for organic acid absorption: non-ionic diffusion and the
counter-transport of organic anions and bicarbonate ions. A local
fall in pH induced by a flux through Na1H ion antiporter seems
to aid absorption by either mechanism because the secreted H
ions favor the formation of the free acid for non-ionic diffusion
and the lower concentration of bicarbonate in the lumen will favor
its countertransport into, and that of organic acids out of the
lumen. The velocity of absorption in some studies is linearly
related to the luminal concentration of organic anions and is not
saturable, whereas in other experiments, the counter-transport
system seems to be dominant and saturable; nevertheless, the
capacity for absorption is large. Hence a large amount of organic
acids can be absorbed if they are produced rapidly in the GI tract.
Metabolic fates of organic acids added to the body
The metabolic fates of the organic acids produced in the GI
tract differ. As discussed above, as much as 50 mmoles of the
butyric acid produced can be oxidized directly by the colonic
mucosal cells. In contrast, almost all the propionate is cleared by
the liver, being converted to glucose, triglycerides or CO2 [33]
Very high rates of production of organic acids in the GI tract
will depend on three major factors: (1) the number, location and
metabolic capacities of bacteria in the GI tract; (2) the supply of
substrates delivered to these bacteria; and (3) the length of time
these bacteria and substrates remain in contact in a milieu which
is favorable for endogenous acid production (preventing a sudden
and large fall in pH in this microenvironment for the most part
[5]) (Fig. 3).Quantitatively, D-lactic acid is normally a minor compound
formed in the GI tract. However, if a large quantity of glucose and
appropriate bacteria meet in a metabolically friendly environment
(a relatively high pH and buffer capacity), anaerobic fermentation
by bacteria can be very rapid and L- and/or D-lactic acids will be
major products, depending on the specific bacterial population
(Fig. 1). When GI bacteria come in contact with a large supply of
dietary nutrients, not only are organic acids produced, but also a
variety of noxious materials accumulate. These could include
aldehydes, alcohols, mercaptans, and amines, some of the latter
may act as false neurotransmitters which may explain some of the
neurological manifestations commonly seen in these patients [13,
37—39]. It has also been suggested that D-lactate and/or a change
in the redox potential might also contribute to these prominent
neurological manifestations [40].
Requirements for organic acid over-production in the GI tract
We shall first consider how the system of maintaining separa-
tion of sugars and bacteria might break down, and the factors that
may favor the over-production of organic acids by bacteria in the
GI tract.
Bacteria have not migrated upstream from the colon, but sugar is
not absorbed normally in the small intestine. The best example of
this scenario is the syndrome of lactose intolerance. In this
disorder, the enzyme required to hydrolyze the disaccharide from
milk (lactose) does not have sufficient capacity to hydrolyze all the
dietary lactose to its component monosaccharides, a required step
to permit their complete absorption. Lactose is now delivered to
colonic bacteria which metabolize it readily, yielding a variety of
organic compounds that cause local irritation to the colonic
mucosa. If organic acids are produced and absorbed, this rate of
input does not exceed the normal metabolic capacity of the host to
remove them so no important systemic acid-base disturbance
occurs. One factor that might prevent the development of sys-
temic acidosis is that the acids produced are provided after meals
Glucose
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(FAST)
2 ATP
2 Lactate- u— 2 Pyruvate + 2 H
Small
intestine
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Fig. 2. Metabolic fate of oanic acids
produced by the GI tract. There are two
families of organic acids depending on
whether they yield pyruvate or not as a
metabolic product. Organic anions that cannot
be converted to pyruvate can only be oxidized,
converted to storage fat, or be converted to
ketoacids, and not be substrates for the net
synthesis of glucose. Fatty acid synthesis only
occurs at appreciable rates when insulin levels
are high (with meals). Abbreviations are:
PDH, pyruvate dehydrogenase; TCA,
tricarboxylic acid cycle; ETS, electron
transport system.
Fig. 3. Clinical conditions resulting in over-
production of o,anic acids in the GI tract. For
over-production or organic acids by bacterial
fermentation, one needs to deliver glucose to
bacteria in the colon (poor absorption, rapid
transit), or have certain bacteria colonize in
the GI tract prior to the site of absorption of
glucose. The clinical picture will also depend
on whether the acids produced can be
absorbed.
when insulin levels are high so that glycogen synthesis [18] and
lipogenesis can occur [41] (Fig. 2).
Migration of bacteria up the small intestine so that they can
encounter sugars before they are completely absorbed. Bacteria may
migrate into, or persist in the lumen of the small intestine for two
major reasons. First there may be an anatomical lesion such as a
short bowel or a blind loop which provides the opportunity for
bacteria to colonize a location prior to complete absorption of
sugar. Second, pharmacologic agents or disease states may slow
bowel motility to a sufficient degree so that bacteria may migrate
into, and multiply in the lumen of the small intestine, thereby
accentuating the production and absorption of organic acids (see
below).
Conditions favoring over-production of organic acids in the GI
tract.
(a) Supply of substrate to the bacteria. There is a clinical
observation that in the suitable host, D-lactic acid accumulation
may be exacerbated by feeding [13—16]. When there is bacterial
overgrowth in the small intestine, the concentration of brush-
border enzymes may decrease [27]. Thus ingested disaccharides
and complex carbohydrates may not be hydrolyzed at an adequate
rate because of low luminal disaccharidase activity. These sugars
may then be fermented by bacteria which have colonized the small
intestine or may be delivered to the colon where they can undergo
anaerobic fermentation by colonic bacteria.
Clinically, one can take advantage of the rate of appearance of
Glucose
___________ I
D-Lactate —p.PyrPropionate
fl
Fatty acids
PDH Acetate
-.Acetyl-CoA4—— Butyrate
TCA
ADPBiologic work ETS
C02+ H20
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organic acids to deduce whether bacteria are still metabolically
active in the small intestine. For example, once the metabolic
acidosis due to over-production of organic acids is well controlled,
the patient could be given a "diagnostic challenge," the consump-
tion of a small quantity of sugar. If organic acids accumulate in
plasma or urine, or if there is a fall in the plasma [HC031
because organic acids accumulated within the GI tract, one can
infer that bacterial overgrowth may still be a potential hazard; a
more specific, prolonged, and/or aggressive therapy is needed.
(b) Bacterial populations. Not all bacteria produce organic acids
in general, or the specific ones such as D- versus L-lactic acid at
equivalent rates. For example, the lactobacillae are much more
likely to generate lactic acid than other species such as clostridia
in the normal colonic flora. A decrease in luminal pH favors the
growth of the acid tolerant bacterial species such as lactobacillus
and the disappearance of the predominant, less acid tolerant gut
flora [5]. Lactobacilli possess the enzyme DL-lactate racemase,
and hence D-lactate may be formed from pyruvate via D-lactate
dehydrogenase or from L-lactate by racemization [421. Thus
measures such as the use of antibiotics which change the propor-
tions and amounts of bacteria in the GI tract may lead to an
altered rate of production of D-lactic acids [51.
(c) Local pH. Two main factors have been proposed to cause
bacterial overgrowth in the small intestine. First, certain bacteria
(such as lactobacilli) increase in number in direct proportion to
the presence of a more acid luminal fluid pH. Second, organic acid
production may be influenced by the luminal fluid pH [43]. In
more detail, when one of the products (H) of anaerobic glyco-
lysis accumulates, the rate of glycolysis declines [I; a proposed
mechanism is that H inhibits a key regulatory enzyme, phospho-
fructokinase-1 [45]. If the same type of controls were to operate in
the bacterial species that happened to populate the area of the GI
tract that received carbohydrates in the luminal fluid, one could
speculate that more lactic acid might be formed if the fluid
bathing these bacteria had a larger buffer capacity. Hence if more
bicarbonate-rich fluid were delivered to the site where fermenta-
tion occurs due, for example, to the ingestion of alkali or the use
of blockers of gastric HC1 secretion such as H2-antagonists or
inhibitors of the gastric H/K ATPase, one might find a larger
production of organic acids by this fermentation route. Although
one might reach a similar "limiting" low luminal pH, the quantity
of organic acids produced could differ markedly depending on the
buffer capacity of the fluid delivered there. It is important to recall
that the [H] at a pH of 5 is only 0.01 mmol/liter, representing an
exceedingly small quantity of organic acids in the absence of
suitable H acceptors.
Acid-base aspects of organic acid production in the GI tract
The primary basis of the metabolic acidosis due to organic acids
such as D-lactic acidosis is an accelerated rate of production.
Nevertheless, metabolism of organic acids occurs primarily in the
liver, but also in organs such as the kidney. Hence with liver and
renal failure, the degree of organic acid accumulation could be
much greater for a given rate of production in the GI tract. To
analyze the acid-base consequences from a quantitative perspec-
tive, several biochemical and metabolic considerations must be
appreciated. Our approach to this problem will be as follows: first,
we use a "metabolic process" analysis because this permits us to
focus only on substrates and products, ignoring all metabolic
intermediates and cofactors. In this way, we can simplify all
metabolic pathways into three overall processes: (1) the conver-
sion of dietary fuels to energy storage compounds (glycogen,
triglycerides), (2) the conversion of dietary, or (3) the conversion
of storage fuels to yield ATP as needed [46]. Only the latter two
processes, if interrupted, have acid-base consequences. Another
important metabolic aspect of regulation of organic acid removal
is the ability of the patient to oxidize these fuels. Here, two points
will be stressed. There is a limit on the capacity to oxidize fuels, a
limit set by the rate of turnover of ATP. Even within this latter
constraint, the competition between fuels as the precursor to be
oxidized to yield the needed ATP sets another limit of the rate of
oxidation of a specific fuel.
Metabolic process analysis
To define whether H are produced or removed during metab-
olism, one need only count the valence of all substrates and
products involved in that process [46]. The sum of the valence of
cofactors can be ignored as these cofactors are both formed and
removed and they are present in only catalytic amounts. When the
net valence of products is more anionic or less cationic than
substrates, H have accumulated; the converse is also true.
Further, one need not be concerned with which organ performs
the metabolism because metabolic processes typically span more
than one organ (Fig. 4).
One can define the metabolic process involving D-lactic acid as
follows: the key steps are first, the mixing of neutral sugars and
bacteria; second, anaerobic fermentation of sugars by bacteria
yielding D-lactate anions plus H; third, the possible absorption
of these organic acids from the GI tract; fourth, retention of the
H and anions in the body; fifth, if these anions are converted to
neutral end-products in the body (glucose, glycogen, triglycerides
Gltract
Substrate
CO2 + H20
W ,"ll organs with
mitochondria)Acetate-
Neutral fat
(Liver)
End-productsMiddle steps
Fig. 4. Metabolic processes and H ion balance. In
this metabolic process, the starting point is dietary
sugar and the end point is either exhaled CO2 or
storage fat. This has no acid-base consequences.
Should either more acetic acid be produced or if the
metabolism of acetic acid by the host be slowed
down, acetic acid could accumulate and cause
metabolic acidosis.
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Fig. 5. Acceleration of the oxidation of D-lactate i'
insulin. Insulin may lead to an increase in the rate of
oxidation of D-lactate by decreasing the supply of
fatty acids, the alternate fuel.
or CO2 plus 1-120) or if the anions are excreted in the urine with
NH4 or H, acidosis is avoided.
Removal of organic acids by host metabolism, quantitative and
metabolic considerations
Pertinent principles of metabolic regulation. Three important
aspects of metabolic regulation that are central to this discussion
will be examined. First, fuels can only be metabolized in organs
which possess the enzymes to initiate their metabolism. This in
fact means the liver for many fuels [461. Second, the rate of
conversion of ATP to ADP (performance of biologic work) sets
the upper limit on the rate of oxidative metabolism [17, 47]. Third,
there is a competition between fuels for oxidation, largely con-
trolled by the activity of the enzyme pyruvate dehydrogenase
(PDH) (Fig. 2) [18]; PDH is inhibited when fatty acids are
oxidized [48, 49].
The organic acids that are absorbed from the GI tract are
delivered to the liver via the portal blood. From the point of view
of hepatic metabolism, one can divide these organic acids into two
classes depending on whether their immediate metabolism yields
the substrate (pyruvate) or the product (acetyl-CoA) of PDH (Fig.
2). In simplest terms, those organic anions which cannot be
converted to pyruvate (butyrate, acetate) have only three possible
major metabolic fates: (1) oxidation yielding ATP, CO2 and water;
(2) with the appropriate hormonal milieu (high insulin and low
glucagon levels in the fed state [50, 51], they may become substrates
for the synthesis of long-chain fatty acids; (3) if lipogenesis is
inhibited, the acetyl-CoA may be converted to ketoacids if hepatic
need for ATP regeneration has already been largely accomplished by
the oxidation of some of these organic acids or long-chain fatty acids
of endogenous origin [17, 52, 53]. In contrast, organic anions such as
D-lactate and propionate can be converted to pyruvate which, in
turn, can be made into glucose or glycogen in the liver or kidney
Table 1. Quantitative considerations for the oxidation of organic acids
Organic acid Number H/mole
ATP yield upon
complete oxidation
Acetic acid 1 10
Butyric acid 1 25
Propionic acid 1 18
D-lactic acid 1 17
cortex (Fig. 2). Hence the options for removal of these organic acids
by metabolic means are greater.
Enzymes to initiate the metabolism of D-lactic acid. Although
humans lack D-lactate dehydrogenase, they do metabolize D-
lactate [54—57]. The specific enzyme to initiate the metabolism of
D-lactate is D-a-hydroxy acid dehydrogenase [58—60], a flavopro-
tein enzyme with high activity in the liver and kidney cortex. Oh et
al [54] estimated that at a serum concentration of 5 to 6 mEqlliter,
a 70 kg man would be able to metabolize about 2500 mmoles of
D-lactate per day. Nevertheless, the overall rate of oxidation of
L-lactate is considerably faster than its D-isomer [54, 55]. Esti-
mates from total body clearance rates suggest that the L-isomer is
metabolized at a rate that is close to fivefold greater than
D-lactate. A note of caution is important here. These data only
apply to the clinical settings under which these experiments were
carried out. Different rates would likely apply depending on the
hormonal milieu (activity of PDH) and the overall rate of ATP
turnover.
Availability of ADP. The rate of oxidation of organic anions and
thereby the ability to remove H ions by metabolism may be
influenced by the rate of metabolic work (the rate of generation of
ADP to permit oxidative metabolism [17, 19]). To the extent that
a patient is hypothermic, has low motor activity, or received drugs
that slow the metabolic rate such as sedatives or anaesthetics, the
Glucose
Pyruvate —
/
Insulin Fatty acids
Pyruvate
m Acetyl-C0A
ADP
work/02 ATP Biologic
Organic acids CO2 + H20
Dehydrogenase
Formed in the large
intestine of the GI tract
Carbohydrate
Fig. 6. Organic acids and metabolic acidosis.
Organic acids have been produced as illustrated
in the center of the diagram. All fates to the left
of the dashed line have no acid-base
consequences because bicarbonate is produced
when the organic anion is metabolized to a
neutral end-product (top left) or is excreted with
H or NH4 ions (bottom left). In contrast,
acidosis is produced with fates to the right of the
dashed line, when the organic anions are
retained in the body (top right) or excreted as
their Na and/or K salts (bottom right).
rate of oxidation of all fuels, including organic acids, will be
slower. This in turn, could lead to a greater degree of metabolic
acidosis when the rate of organic acid production is high.
Control by fuel selection. The availability of fuels competing for
oxidation may slow the rate of oxidation of D-lactic acid. For
example, when insulin is deficient, a greater availability of fatty
acids may lead to a lower rate of oxidation of D-lactic acid given
the relatively fixed rate of ATP turnover. Hence we speculate that
the administration of insulin, which should diminish the availabil-
ity of fatty acids, might lead to a greater rate of oxidation of
organic acids produced in the GI tract (Fig. 5); there are no data
to test this hypothesis. Therefore, in a special case where meta-
bolic acidosis with an elevated anion gap is very severe and
increasing in degree, this option for therapy could be considered.
Steps must also be taken to avoid hypoglycemia and a severe
degree of hypokalemia. It would be interesting to evaluate this
potential therapeutic approach in future clinical studies.
There is yet another way the degree of organic acidosis may be
influenced by fuel selection, that is, the competition of these
organic acids for oxidation. For example, if acetyl-CoA, the
product of acetic acid and butyric acid oxidation accumulates, it
will lead to inhibition of PDH (Fig. 2) [48, 49, 61, 62].Therefore,
with the combined production of acetic and D-lactic acids, only
D-lactic acid may accumulate if oxidation is the primary metabolic
fate of these acids. Moreover, the stoichiometry between proton
removal and ATP regeneration is not identical for these organic
acids of GI origin (Table 1). For example, the complete oxidation
of 1 mmol of acetic acid will regenerate 10 mmol ATP [63]. In
contrast, the complete oxidation of 1 mmol of butyric, D-lactic, or
propionic acid will regenerate close to twice this quantity of ATP.
Since each of these organic anions has a valence of one, they are
all associated with the same H load on a molar basis. Hence for
a given rate of turnover of ATP, the accumulation of H would be
twice as high with the latter three organic acids than with the same
molar load of acetic acid if oxidation was their only metabolic fate.
Clinical presentation, the plasma anion gap
There are two major ways acidosis is defined from routine
laboratory data. First, organic acids may be added to the body so
quickly that both the H and the anion are retained; this results
in metabolic acidosis and an elevated value for the plasma anion
gap [64—66] (upper right portion of Fig. 6). Second, metabolic
acidosis may be present without a rise in the plasma anion gap. In
this latter setting, either the D-lactate anion was retained in the
lumen of the GI tract (with the H being absorbed or titrated by
bicarbonate in the lumen of the GI tract), or it was excreted in the
urine, but in either case, the cation lost with it was Na and/or K
ion [671 (not a H or NH4 ion, lower right portion of Fig. 6).
This latter type of metabolic acidosis is akin to the over-produc-
tion of hippuric acid in glue sniffers [68]. Since D-lactate anions
are reabsorbed by the kidney much less readily than is L-lactate
[54, 69, 70], as time progresses, the anion gap may decline without
resulting in a rise in the plasma bicarbonate concentration-that is,
D-Iactate is excreted as its Na or K salt (Fig. 6). Hence there
are a number of mechanisms that may contribute to the presen-
tation whereby the rise in the plasma anion gap might not match
the fall in the plasma bicarbonate concentration. Not only might
this lead to a diagnostic problem, it has implications for therapy
because, once the organic anions are excreted as their Na or
salts, these anions are no longer available for metabolism to
regenerate bicarbonate, and the patient might have developed a
deficit of Na and/or K4.
Renal aspects: Excretion of organic anions with or without NH4
Metabolic acidosis will occur if the organic anions are excreted
in the urine with a cation other than H or NH4. Very few of
these organic anions are excreted in appreciable amounts with H
ions because their pKs are not greater than 5. One might
anticipate that the rate of excretion of NH4 might be lower than
expected for a number of reasons in patients with a high rate of
production of organic acids in the GI tract. Coexistence of renal
damage may be due directly to the GI lesion, drugs used to treat
that GI problem, or even indirectly via chronic hypokalemia [71,
721. In addition, several other factors might operate to lower the
rate of excretion of NH4. First, if the over-production of acids is
acute, a high rate of excretion of NH4 is not expected because
there is normally a lag period of days before NH4 production is
augmented [73]. Second, if the patient is malnourished, the level
of glutamine in plasma may be low enough to limit renal NH4
production [74]. Third, since the production of NH4 also results
in the regeneration of ATP in cells of the proximal tubule [75],
two additional mechanisms might lead to a lower rate of NH4
Body
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excretion: (1) a lower filtered load of Na due to a low GFR
because of ECF volume contraction lessens the need for con-
sumption of ATP (Nat reabsorption) in the proximal tubule. (2)
If the organic acids are oxidized in proximal tubular cells to yield
ATP, less glutamine can now be metabolized in these cells, and
hence the rate of ammoniagenesis could decline for this reason as
well [731.
Concluding remarks
There are a variety of clinical presentations when organic acids
are over-produced in the 01 tract. In its most benign form, there
is no systemic acid-base disorder, but local colonic irritation with
crampy pain and diarrhea are the main complaints, as in lactose
intolerance. The most common clinical acid-base disturbance
related to organic acid production in the GI tract is metabolic
acidosis with an increased anion gap in plasma. A third type of
presentation is metabolic acidosis with a lower than expected rise
or even a near normal anion gap in plasma. Its pathophysiology
could include two different explanations. First, there may be the
renal excretion of organic anions such as D-lactate without H or
NH4 ions and reflects the fact that the D-isomer is less well
reabsorbed in the proximal convoluted tubule than the normal
L-isomer of lactic acid. Second, some patients with a short bowel
may lose the Na salt of D-lactic acid in the stool, which also causes
metabolic acidosis without a rise in the plasma anion gap [the H,
hut not the organic anion is reabsorbed (or reacts with secreted
bicarbonate in the lumen of the GI tract)]. The metabolic consider-
ations that might limit the rate of removal of H by metabolism of
anions or the urinary excretion of NH4 in these patients were
addressed. While limiting the supply of dietary sugars to intestinal
bacteria may lessen the degree of acidosis, organic acids may be
removed more rapidly by oxidation if the availability of the compet-
ing fuels such as fatty acids is decreased. The oral administration of
poorly absorbable antibiotics (such as vancomycin, neomycin) was
shown to be beneficial in eliminating the pathological bacteria in
some of these patients [3, 5, 11]. Surgical intervention which in-
creases the length of intestinal surface for absorption of sugar or
re-establishing intestinal continuity may be necessary in some pa-
tients with D-lactic acidosis associated with intestinal bypass [42].
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